These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 3931446)
1. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent. Morganroth J; Nestico PF; Horowitz LN Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446 [TBL] [Abstract][Full Text] [Related]
2. Tocainide: a new oral antiarrhythmic agent. Kutalek SP; Morganroth J; Horowitz LN Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807 [TBL] [Abstract][Full Text] [Related]
3. Tocainide: a new oral antiarrhythmic. Hasegawa GR Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308 [TBL] [Abstract][Full Text] [Related]
4. Tocainide. A review of its pharmacological properties and therapeutic efficacy. Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445 [TBL] [Abstract][Full Text] [Related]
5. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine. Alpert JS; Haffajee CI; Young MD Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205 [TBL] [Abstract][Full Text] [Related]
6. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias. Nestico PF; DePace NL; Morganroth J Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of class I antiarrhythmic agents. Legrand V; Collignon P Drugs; 1985; 29 Suppl 4():54-7. PubMed ID: 3924551 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction. Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252 [TBL] [Abstract][Full Text] [Related]
11. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Hashimoto K; Ishii M; Komori S; Mitsuhashi H Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304 [TBL] [Abstract][Full Text] [Related]
13. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine. Snyder DW J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645 [TBL] [Abstract][Full Text] [Related]
14. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias. Schwartzkopff B; Schilling G; Simon H Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021 [TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic drug therapy of ventricular arrhythmias. Huang SK; Marcus FI Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035 [No Abstract] [Full Text] [Related]
16. Tocainide for arrhythmias. Med Lett Drugs Ther; 1985 Feb; 27(680):9-11. PubMed ID: 3918240 [No Abstract] [Full Text] [Related]
17. Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents. Roden DM Postgrad Med; 1985 Sep; 78(4):28-37. PubMed ID: 2412217 [No Abstract] [Full Text] [Related]
18. The role of antiarrhythmic drugs in prevention of sudden cardiac death. Podrid PJ Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903 [No Abstract] [Full Text] [Related]
19. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias. Morganroth J; Oshrain C; Steele PP Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ; Easley AR; Mann DE Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]